🧬 Biotech Catalyst Calendar

Updated daily · catalystalert.io + dansfera.com Admin
7
Upcoming
3
This Month
0
Trial Readouts
0
PDUFA Dates
7
AdCom Votes
Type: All 🔬 Trial 💊 PDUFA 🏛️ AdCom 📊 Earnings
Mkt Size: All ≥$1B ≥$5B ≥$10B ≥$50B
Date Ticker Company Drug Type Phase PoA Mkt Size Notes
2026-04-30
in 2 days 		AZN AstraZeneca PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (mHSPC) Truqap (capivasertib (Truqap) + abir AdCom — 92% $8B APR 30 2026 2 days 🏛️ AdCom Truqap (capivasertib (Truqap) + abir...) $AZN AstraZeneca PTEN
2026-04-30
in 2 days 		AZN AstraZeneca HR+/HER2- advanced breast cancer — first-line with emergent ESR1 mutation camizestrant (NDA 220359 AdCom — 85% $12B APR 30 2026 2 days 🏛️ AdCom (camizestrant (NDA 220359)) $AZN AstraZeneca HR+/HER2- advance
2026-04-30
in 2 days 		AZN — — AdCom — 92% — APR 30 2026 2 days 🏛️ AdCom Truqap (capivasertib (Truqap) + abir...) $AZN AstraZeneca PTEN
2026-06-03
in 175 days 		CYTK Cytokinetics Obstructive hypertrophic cardiomyopathy (oHCM) MYQORZO (aficamten AdCom — 85% $4B JUN 3 2026 36 days 🏛️ AdCom MYQORZO (aficamten) $CYTK Cytokinetics Obstructive hypertrophi
2026-06-03
in 175 days 		CYTK — — AdCom — 85% — JUN 3 2026 36 days 🏛️ AdCom MYQORZO (aficamten) $CYTK Cytokinetics Obstructive hypertrophi
2026-08-20
in 392 days 		KALV KalVista Pharmaceuticals Hereditary angioedema (HAE) — on-demand oral treatment donidalorsen AdCom — 85% $1B AUG 20 2026 114 days 🏛️ AdCom (donidalorsen) $KALV KalVista Pharmaceuticals Hereditary ang
2026-08-20
in 392 days 		KALV — — AdCom — 85% — AUG 20 2026 114 days 🏛️ AdCom (donidalorsen) $KALV KalVista Pharmaceuticals Hereditary ang